[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Codexis Inc (CDXS)

Codexis Inc (CDXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 238,077
  • Shares Outstanding, K 90,869
  • Annual Sales, $ 70,390 K
  • Annual Income, $ -43,970 K
  • EBIT $ -38 M
  • EBITDA $ -31 M
  • 60-Month Beta 2.08
  • Price/Sales 3.25
  • Price/Cash Flow N/A
  • Price/Book 4.50

Options Overview Details

View History
  • Implied Volatility 152.45% (-10.02%)
  • Historical Volatility 80.70%
  • IV Percentile 48%
  • IV Rank 18.62%
  • IV High 717.94% on 02/10/26
  • IV Low 23.08% on 09/09/25
  • Expected Move (DTE 18) 1.11 (41.39%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 139
  • Volume Avg (30-Day) 132
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 2,324
  • Open Int (30-Day) 1,671
  • Expected Range 1.57 to 3.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.12
  • Number of Estimates 2
  • High Estimate $-0.02
  • Low Estimate $-0.22
  • Prior Year $-0.25
  • Growth Rate Est. (year over year) +52.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.50 +76.33%
on 03/30/26
2.84 -6.87%
on 04/27/26
+1.06 (+67.41%)
since 03/27/26
3-Month
0.96 +176.01%
on 03/04/26
2.84 -6.87%
on 04/27/26
+1.22 (+84.97%)
since 01/27/26
52-Week
0.96 +176.01%
on 03/04/26
3.87 -31.65%
on 08/14/25
+0.38 (+17.04%)
since 04/25/25

Most Recent Stories

More News
Codexis to Report First Quarter 2026 Financial Results on May 7

REDWOOD CITY, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 2.65 (+1.15%)
Codexis: Q4 Earnings Snapshot

Codexis: Q4 Earnings Snapshot

CDXS : 2.65 (+1.15%)
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

      Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash equivalents and short-term investments,...

CDXS : 2.65 (+1.15%)
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform

REDWOOD CITY, Calif. , March 4, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...

CDXS : 2.65 (+1.15%)
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11

REDWOOD CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 2.65 (+1.15%)
Codexis to Participate in TD Cowen 46th Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 2.65 (+1.15%)
Codexis Achieves ISO 9001:2015 Certification

REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that...

CDXS : 2.65 (+1.15%)
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

REDWOOD CITY, Calif. , Jan. 7, 2026 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part...

CDXS : 2.65 (+1.15%)
Codexis Announces Signing of Lease for GMP Manufacturing Facility

REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today...

CDXS : 2.65 (+1.15%)
Codexis: Q3 Earnings Snapshot

Codexis: Q3 Earnings Snapshot

CDXS : 2.65 (+1.15%)

Business Summary

Codexis is a leading protein engineering company that applies its proprietary CodeEvolver technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and...

See More

Key Turning Points

3rd Resistance Point 2.87
2nd Resistance Point 2.77
1st Resistance Point 2.70
Last Price 2.65
1st Support Level 2.52
2nd Support Level 2.42
3rd Support Level 2.35

See More

52-Week High 3.87
Fibonacci 61.8% 2.76
Last Price 2.65
Fibonacci 50% 2.41
Fibonacci 38.2% 2.07
52-Week Low 0.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.